lobbying_activities: 506656

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
506656	b1a66835-d758-411f-82c8-58015acafa57	MM	KAISER FOUNDATION HEALTH PLAN INC.	21027	KAISER FOUNDATION HEALTH PLAN INC	2007	mid_year	PHA	"Preserve Access to Affordable Generics Act" - S 316 To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, issues relating to health plans. Sponsor: Sen. Kohl	HOUSE OF REPRESENTATIVES,SENATE		320000	0	0	2007-07-27T17:18:40-04:00